Viewing Study NCT06530550


Ignite Creation Date: 2025-12-24 @ 4:51 PM
Ignite Modification Date: 2026-01-07 @ 12:28 PM
Study NCT ID: NCT06530550
Status: RECRUITING
Last Update Posted: 2025-08-12
First Post: 2024-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module